Improved secretion of the cancer-testis antigen SSX2 in Pichia pastoris by deletion of its nuclear localization signal

被引:0
作者
Chung-Jr Huang
Kyle A. Anderson
Leonardo M. Damasceno
Gerd Ritter
Lloyd J. Old
Carl A. Batt
机构
[1] Cornell University,Field of Microbiology
[2] Memorial Sloan Kettering Cancer Center,Ludwig Institute for Cancer Research, New York Branch
[3] Sanofi Pasteur,undefined
来源
Applied Microbiology and Biotechnology | 2010年 / 86卷
关键词
Cancer-testis antigen; SSX2; Recombinant protein secretion; Nuclear localization signal; Delayed-type hypersensitivity;
D O I
暂无
中图分类号
学科分类号
摘要
The cancer-testis (CT) antigen synovial sarcoma X break point 2 (SSX2) was expressed in Pichia pastoris as a means to produce a delayed-type hypersensitivity skin test reagent for monitoring SSX2-specific anti-cancer immune responses. SSX2 was detected intracellularly in P. pastoris despite the addition of the Saccharomyces cerevisiae alpha-mating factor secretion signal. Increasing the SSX2 gene copy number did not improve its secretion but did enhance intracellular SSX2 levels. SSX2 with its C-terminal nuclear localization signal (NLS) deleted (SSX2NORD), however, was secreted. Indirect immunofluorescence indicated that SSX2 containing the NLS did not translocate to the nucleus but accumulated in the endoplasmic reticulum (ER). Experimental results further suggested that SSX2 containing the NLS was misfolded in the ER, while deletion of the NLS facilitated correct folding of SSX2 inside the ER and improved its secretion. Production of SSX2NORD was scaled-up to a 2-L fermentor using a fed-batch protocol to maintain methanol at a concentration of 1 g L−1. Decreasing the cultivation temperature from 25 °C to 16 °C improved protein stability in the culture supernatant. In this process, after 120 h cultivation, the wet cell weight of P. pastoris reached 280 mg mL−1, and the yield of SSX2NORD was 21.6 mg L−1.
引用
收藏
页码:243 / 253
页数:10
相关论文
共 232 条
[1]  
Abdelmoula-Souissi S(2007)High-level expression of human tumour suppressor P53 in the methylotrophic yeast: Protein Expr Purif 54 283-288
[2]  
Rekik L(2002)Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma J Immunol 168 1717-1722
[3]  
Gargouri A(2003)Tumor-reactive, SSX-2-specific CD8 Cancer Res 63 5601-5606
[4]  
Mokdad-Gargouri R(2004) T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients J Clin Invest 113 1225-1233
[5]  
Ayyoub M(2005)An immunodominant SSX-2-derived epitope recognized by CD4 Clin Immunol 114 70-78
[6]  
Stevanovic S(2007) T cells in association with HLA-DR Exp Gerontol 42 864-870
[7]  
Sahin U(1993)Distinct but overlapping T helper epitopes in the 37–58 region of SSX-2 Crit Rev Eukaryot Gene Expr 3 193-227
[8]  
Guillaume P(2005)The proteasome and its role in nuclear protein maintenance J Immunol 174 1709-1716
[9]  
Servis C(2002)Nuclear localization signals (NLS) Curr Opin Biotechnol 13 329-332
[10]  
Rimoldi D(2005)Naturally acquired MAGE-A10- and SSX-2-specific CD8 Curr Biol 15 R907-508